X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
SUN PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 446.1%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 446.1%
Thu, 16 Aug

SUN PHARMA has announced its results for the quarter ended June 2018. Here is a detailed performance review of the same:

SUN PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Jun-17*
3
Mar-18*
3
Jun-18*
QoQ ChangeYoY Change
Net SalesRs m62,08869,77172,2423.5%16.4%
Other incomeRs m1,5203,0281,998-34.0%31.4%
TurnoverRs m63,60872,79974,2392.0%16.7%
ExpensesRs m51,13152,93656,1756.1%9.9%
Gross profitRs m1,45216,83516,067-4.6%1006.9%
DepreciationRs m3,4664,5524,016-11.8%15.9%
InterestRs m1,0941,5541,309-15.8%19.6%
Profit before taxRs m-1,58913,75612,739-7.4%
TaxRs m1,618-1,7671,6391.3%
Profit after taxRs m-3,20715,52311,101-28.5%
Gross profit margin%2.324.122.2
Effective tax rate%-101.8-12.812.9
Net profit margin%-5.021.315.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 16.4% on a year-on-year (YoY) basis. The expenses were up by 9.9% YoY during the same period.
  • The company's operating profit increased by 1006.9% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 22.2% in 1QFY19 as against 2.3% in 1QFY18.
  • Depreciation charges and finance costs increased by 15.9% YoY and 19.6% YoY, respectively.
  • Other income increased by 31.4% YoY during the quarter.
  • Net profit for the quarter increased by 446.1% YoY. Net profit margins during the quarter increased from -5.0% in 1QFY18 to 15.0% in 1QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 3.5% on a quarter-on-quarter (QoQ) basis. The expenses were up by 6.1% QoQ during the same period.
  • The company's operating profit declined by 4.6% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 22.2% in 1QFY19 as against 24.1% in 4QFY18.
  • Net profit for the quarter declined by 28.5% QoQ, while net profit margins declined from 21.3% in 4QFY18 to 15.0% in 1QFY19.

To see how SUN PHARMA has performed over the last eight quarters, please visit here.

SUN PHARMA Share Price Performance

Over the last one year, SUN PHARMA share price has moved up from Rs 485.2 to Rs 615.5, registering a Gain of Rs 130.3 or around 26.9%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,813.1 (up 0.9%). Over the last one year it has moved up from 13,214.8 to 14,813.1, a gain of 1,598 points (up 12.1%).

Overall, the S&P BSE SENSEX is up 20.1% over the year.

Current Valuations

At the current price of Rs 615.5, the price to earnings (P/E) ratio of SUN PHARMA stands at 36.4 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 4.0 times.

Equitymaster requests your view! Post a comment on "SUN PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 446.1%". Click here!

  

Related Views on News

SUN PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 110.7% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, SUN PHARMA has posted a net profit of Rs 1 bn (down 110.7% YoY). Sales on the other hand came in at Rs 69 bn (up 4.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Sep 19, 2018 | Updated on Sep 19, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (4QFY18); Net Profit Up 12.0% (Quarterly Result Update)

May 28, 2018 | Updated on May 28, 2018

For the quarter ended March 2018, SUN PHARMA has posted a net profit of Rs 16 bn (up 12.0% YoY). Sales on the other hand came in at Rs 70 bn (down 2.2% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

More Views on News

Most Popular

It's Almost the Perfect Time to Buy This Safe Stock(The 5 Minute Wrapup)

Dec 6, 2018

My latest StockSelect recommendation ticks all the boxes of a great safe stock.

Patel's Exit, Election Results, and 4 'Must Have' Small Caps in These Exceptional Times(Profit Hunter)

Dec 11, 2018

RBI Governor's resignation is a statement of dissent with the way government is handling the economy's affairs and could lead to some serious market correction. Here's how to make the most of it.

Players in an Oligopoly Should Have Financials Like This(Chart Of The Day)

Dec 7, 2018

This stock has corrected 30% from peak and looks attractive at these valuations.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

DSP Mutual Fund's Sale of DHFL Bonds: Here's What You Need to Know(Outside View)

Dec 5, 2018

PersonalFN explains the probable reason as to why the capital market regulator has initiated DSP Mutual Fund's bond sale that caused DHFL stock to crash.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Dec 14, 2018 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUN PHARMA WITH

MARKET STATS